Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Prophylactic anticoagulants for non-hospitalised people with COVID-19
Brena Costa Santos, Ronald Luiz Gomes Flumignan, Vinicius Tassoni Civile, et al.
Cochrane library (2023) Vol. 2023, Iss. 8
Open Access | Times Cited: 11

Showing 11 citing articles:

Angioplasty or stenting for deep venous thrombosis
Ronald Luiz Gomes Flumignan, Luís CU Nakano, Carolina DQ Flumignan, et al.
Cochrane library (2025) Vol. 2025, Iss. 2
Closed Access
Antiplatelet agents for the treatment of deep venous thrombosis
Carolina DQ Flumignan, Luís CU Nakano, José CC Baptista-Silva, et al.
Cochrane library (2022) Vol. 2022, Iss. 7
Open Access | Times Cited: 21
Pharmacological interventions for preventing venous thromboembolism in people undergoing bariatric surgery
Fabio CF Amaral, José CC Baptista-Silva, Luís CU Nakano, et al.
Cochrane library (2022) Vol. 2022, Iss. 11
Open Access | Times Cited: 16
Pharmacological treatments for vaccine-induced immune thrombocytopenia and thrombosis (VITT) after COVID-19 vaccination
Julia V Magalhaes, Ronald Luiz Gomes Flumignan, Vinicius Tassoni Civile, et al.
Cochrane library (2024) Vol. 2024, Iss. 2
Open Access | Times Cited: 2
The therapeutic potential of sphingolipids for cardiovascular diseases
Sapir Ya’ar Bar, Noam Pintel, Hesen Abd Alghne, et al.
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 3
Prothrombotic state and thrombotic events in COVID-19 pandemic period, including portal vein and splenic artery thromboses
Özgür Karcıoğlu, Canan Akman, G. Öztürk
World Journal of Clinical Cases (2024) Vol. 12, Iss. 33, pp. 6595-6603
Closed Access
Prophylactic-dose direct oral anticoagulants for non-hospitalised people with COVID-19: A meta-analysis of randomised controlled trials
Qingchun Song, Hongduan Liu, Haoyu Tan, et al.
Journal of Global Health (2024) Vol. 14
Open Access
Direct Oral Anticoagulants Consumption and Expenditure in Covid-19 Pandemic in Russia and Clinical Practice Guidelines for Their Use
Elena A. Baybulatova, Liliya Eugenevna Ziganshina, S. К. Zyryanov, et al.
(2023)
Open Access | Times Cited: 1
For non-hospitalized people with COVID-19 at risk of progression, do prophylactic anticoagulants improve outcomes?
Sera Tort, Mario Cruciani
Cochrane Clinical Answers (2023)
Closed Access
Direct Oral Anticoagulants’ Consumption and Expenditure in the COVID-19 Pandemic in Russia and Clinical Practice Guidelines for Their Use
Elena A. Baybulatova, Mikhail S. Chenkurov, Elina Korovyakova, et al.
Pharmacoepidemiology (2023) Vol. 3, Iss. 1, pp. 1-32
Open Access
Page 1

Scroll to top